Inhibition of human multidrug resistance P-glycoprotein 1 by analogues of a potent δ-opioid antagonist

被引:11
作者
Lovekamp, T
Cooper, PS
Hardison, J
Bryant, SD
Guerrini, R
Balboni, G
Salvadori, S
Lazarus, LH
机构
[1] NIEHS, LCBRA, Peptide Neurochem Grp, Res Triangle Pk, NC 27709 USA
[2] Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA
[3] Univ Ferrara, Dept Pharmaceut Sci, I-44100 Ferrara, Italy
[4] Univ Ferrara, Ctr Biotechnol, I-44100 Ferrara, Italy
关键词
Dmt-Tic; delta-opioid receptor antagonists; hMDR1; P-glycoprotein; hydrophobicity;
D O I
10.1016/S0006-8993(01)02363-0
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Analogues Dmt-Tic (2 ' ,6 ' -dimlthyl-L-tyrosine-1,2,3,3-tetrahydroisquinoline-3-carboxylic acid) pharmacophore. a potent delta -opioid receptor antagonist, inhibited hMDRI P-GP expressed in a G-185 fibroblast cell line in a manner similar to verapamil. N,N(Me)(2)-Dmt-Tic-NH-1 -adamantane. H-Dmt-Tic-NH-1-adamantane, H-Dmt-Tic-Ala-NH-1-adamantane and N,N(Me)(2)-Dmt-Tic-NH-tBut were highly effective inhibitors. Weaker inhibition was observed with N,N(Er)(2)-Dmt-Tic-OH, H-Dmt-Tic-Ala-NH-tert-butyl amide and cyclo(Dmt- Tie). Results demonstrate that N- and C-terminal hydrophobic /lipophilic analogues of the Dmt-Tic pharmacophore inhibit hMDR1 and point to a potential role as chemosensitizing agents in chemotherapy for cancers containing hMDR1. (C) 2001 Published by Elsevier Science B.V.
引用
收藏
页码:131 / 134
页数:4
相关论文
共 19 条
[1]  
Abbruscato TJ, 1997, J PHARMACOL EXP THER, V280, P402
[2]   Opioid diketopiperazines: Synthesis and activity of a prototypic class of opioid antagonists [J].
Balboni, G ;
Guerrini, R ;
Salvadori, S ;
Tomatis, R ;
Bryant, SD ;
Bianchi, C ;
Attila, M ;
Lazarus, LH .
BIOLOGICAL CHEMISTRY, 1997, 378 (01) :19-29
[3]   Opioid diketopiperazines: Refinement of the delta opioid antagonist pharmacophore [J].
Bryant, SD ;
Balboni, G ;
Guerrini, R ;
Salvadori, S ;
Tomatis, R ;
Lazarus, LH .
BIOLOGICAL CHEMISTRY, 1997, 378 (02) :107-114
[4]  
CALLAGHAN R, 1993, J BIOL CHEM, V268, P16059
[5]  
CAPASSO A, 1996, LIFE SCI, V59, P93
[6]  
CAPASSO S, 1995, INT J PEPT PROT RES, V45, P567
[7]   Enhanced antinociception of the model opioid peptide [D-Penicillamine2,5] enkephalin by P-glycoprotein modulation [J].
Chen, CP ;
Pollack, GM .
PHARMACEUTICAL RESEARCH, 1999, 16 (02) :296-301
[8]  
Chen CP, 1998, J PHARMACOL EXP THER, V287, P545
[9]   BLOOD-BRAIN-BARRIER RESTRICTION OF PEPTIDES AND LOW UPTAKE OF ENKEPHALINS [J].
CORNFORD, EM ;
BRAUN, LD ;
CRANE, PD ;
OLDENDORF, WH .
ENDOCRINOLOGY, 1978, 103 (04) :1297-1303
[10]   Deltorphin transport across the blood-brain barrier [J].
Fiori, A ;
Cardelli, P ;
Negri, L ;
Savi, MR ;
Strom, R ;
Erspamer, V .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (17) :9469-9474